These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39171161)

  • 21. Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments.
    Zhu M; He Q; Wang Y; Duan L; Rong K; Wu Y; Ding Y; Mi Y; Ge X; Yang X; Yu Y
    Front Pharmacol; 2023; 14():1238841. PubMed ID: 37900162
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-colorectal cancer mechanism of Astragali Radix-Curcumae Rhizoma-Paridis Rhizoma based on network pharmacology and experimental verification].
    Liang Y; Sun RL; Liu FY; Liu TT; Guan HQ; Tang DC
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):776-785. PubMed ID: 35178961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-papillary thyroid carcinoma effects of dioscorea bulbifera L. through ferroptosis and the PI3K/AKT pathway based on network pharmacology and experimental validation.
    Gao Y; Yang Z; Ji T; Zhou P; Geng L; Gao X
    J Ethnopharmacol; 2024 May; 326():117912. PubMed ID: 38387682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
    Qu M; Li J; Yuan L
    Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools,
    Li Y; Yang X; Wang F; Zhao J; Zhang C; Wu D; Yang B; Gao R; Zhao P; Zan Y; Su M; He Z; Liu Y; Wang J; Tang D
    Front Pharmacol; 2023; 14():1076815. PubMed ID: 37229244
    [No Abstract]   [Full Text] [Related]  

  • 28. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
    Zeng T; Ling C; Liang Y
    Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
    Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
    Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of Modified Huoluo Xiaoling Pills against colorectal cancer based on network pharmacology, molecular docking, and experimental validation].
    Jiang W; Zhao QP; Huang L; Jiang JW; Li ML; Chen XC; Xu Y; Wang GJ; Deng L; Zhang LC; Li ZM
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3657-3667. PubMed ID: 39041138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network Pharmacology Analysis and In Vitro Validation of the Active Ingredients and Potential Mechanisms of Gynostemma Pentaphyllum Against Esophageal Cancer.
    Guo J; Wu Z; Chang X; Huang M; Wang Y; Liu R; Li J
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the effects and mechanisms of Erchen Decoction in the treatment of colorectal cancer by network pharmacology and experimental validation.
    Shao Y; Chen J; Hu Y; Wu Y; Zeng H; Lin S; Lai Q; Fan X; Zhou X; Zheng M; Gao B; Sun J
    Front Pharmacol; 2022; 13():1000639. PubMed ID: 36313338
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3β/β-catenin signaling pathways: a network pharmacology-directed experimental investigation.
    Zhuang J; Mo J; Huang Z; Yan Y; Wang Z; Cao X; Yang C; Shen B; Zhang F
    Chin Med; 2023 Aug; 18(1):104. PubMed ID: 37608369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
    Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
    Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics Analysis to Screen Key Targets of Curcumin against Colorectal Cancer and the Correlation with Tumor-Infiltrating Immune Cells.
    Han X; Yang C; Guo C; Xu Y; Liu X; Xie R; Meng X; Cheng Z; Fu X
    Evid Based Complement Alternat Med; 2021; 2021():9132608. PubMed ID: 34804186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apigenin inhibits proliferation and differentiation of cardiac fibroblasts through AKT/GSK3β signaling pathway.
    Kan H; Wang P; Yang Y; Jia H; Liu A; Wang M; Ouyang C; Yang X
    J Ethnopharmacol; 2024 Nov; 334():118518. PubMed ID: 38964628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of UPLC-QE-MS/MS and network pharmacology to investigate the active components and action mechanisms of tea cake extract for treating cough.
    Lin C; Liu Z; Chen J; Wang X; Zhang R; Wu L; Li L
    Biomed Chromatogr; 2022 Oct; 36(10):e5442. PubMed ID: 35781817
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ma L; Ai F; Xiao H; Wang F; Shi L; Bai X; Zhu Y; Ma W
    Front Pharmacol; 2024; 15():1367747. PubMed ID: 38576495
    [No Abstract]   [Full Text] [Related]  

  • 40. Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking.
    Ren J; Mo Z; Huang Z; Li S
    Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38638040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.